Business context and reporting period
Marathon Patent Group, Inc. (the registrant named in this 10-Q; not identified here as MARA Holdings, Inc.) reported unaudited results for the three months ended March 31, 2014. Its business was acquiring and monetizing patent rights through licensing and enforcement. The company had discontinued its minerals and real-estate businesses.
Financial results and liquidity
| Metric | Q1 2014 | Q1 2013 |
|---|---|---|
| Revenue | $2.780 million | $0 |
| Gross profit / margin | $1.669 million / approximately 60% | Not meaningful; no revenue |
| Operating expenses | $1.951 million | $714,377 |
| Operating loss | $281,833 | $714,377 |
| Net loss | $281,606; $0.05 per share | $605,536; $0.17 per share |
| Operating cash flow | $1.800 million provided | $233,175 used |
Cash rose to $5.411 million from $3.610 million at year-end. Current assets were $6.276 million and current liabilities $1.750 million, implying working capital of $4.526 million. Total assets were $14.137 million; total liabilities were $1.750 million. No debt is reported on the March 31 balance sheet. Operating cash flow benefited from a $964,297 increase in accounts payable and accrued expenses and substantial noncash expenses, including $453,647 patent amortization and $680,627 in stock-based compensation and consulting. The company collected $2.5 million of revenue during the quarter and reported $280,000 of receivables, which it said were collected in April.
Material changes and management commentary
Revenue came from patent enforcement and two settlement and license agreements; two customers accounted for approximately all quarterly revenue, and one customer represented all net receivables at quarter-end. Compared with Q1 2013, operating expenses increased 173%, principally reflecting patent amortization, higher headcount, and increased consulting costs. Net loss narrowed 53%, mainly because of the new revenue. Q1 2013 included $108,780 income from discontinued operations; Q1 2014 did not.
Management said March 31 cash was sufficient to fund current operations at least through October 2015, while cautioning that operating changes could require earlier additional financing. The filing gives no specific operating or revenue guidance. Management also disclosed that disclosure controls were ineffective at quarter-end because of limited internal resources and insufficient multi-level transaction review; remediation was planned but not assured.
Subsequent events, risks and unusual items
After quarter-end, the company raised $6.503 million gross in a May 1 private placement of 8% Series A preferred stock and warrants. It also completed May 2 acquisitions of three IP-related businesses. The transactions included a total $5.0 million second cash installment evidenced by notes, generally due by June 30, 2014; the amount could increase to $6.0 million if not paid by then. The notes mature October 30, 2014. Sellers may also receive contingent payments tied to future recoveries, subject to a stated $250 million cap. These material post-quarter transactions change the context of the March 31 liquidity position.
Series A preferred stock carries an 8% annual dividend and a $6.50-per-share liquidation preference; preferred conversion and warrant exercise could materially dilute common shareholders. The company also disclosed a seven-year office lease beginning May 1, 2014, with stated minimum payments totaling $320,469 for the periods shown. Management cited risks inherent in patent monetization, uncertain recoveries, potential need for additional capital, and estimates used to value and test patent assets. Cash balances exceeded the FDIC insurance limit at one institution.
Important facts for investors to verify
- Confirm the issuer and filing identity: this document is for Marathon Patent Group, Inc. for Q1 2014.
- Review customer concentration, collection timing, and whether patent-enforcement revenue is repeatable.
- Assess operating cash flow quality, including the large increase in accrued liabilities and noncash expenses.
- Verify the payment status and terms of the post-quarter acquisition notes, including the June 30 deadline and potential increase to $6.0 million.
- Evaluate the preferred dividend, liquidation priority, warrants, contingent seller payments, and resulting dilution.
- Track remediation of the disclosed ineffective disclosure controls and the CFO transition disclosed after quarter-end.